Pacira BioSciences (PCRX) Other Accumulated Expenses (2011 - 2012)
Pacira BioSciences (PCRX) posted quarterly Other Accumulated Expenses of $360000.0 for Q4 2012, up 4.35% year-over-year from $345000.0 in Q1 2012, and up 4.35% quarter-over-quarter from $345000.0 in Q4 2011.
Pacira BioSciences (PCRX) Other Accumulated Expenses (2011 - 2012) Analysis & Trends
Pacira BioSciences' Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $360000.0 for Q4 2012.
- In Q4 2012, Other Accumulated Expenses rose 4.35% year-over-year to $360000.0; the TTM figure through Dec 2012 stood at $360000.0 (up 4.35% YoY), while the FY2012 annual figure was $360000.0, up 4.35% from the prior year.
- Other Accumulated Expenses for Q4 2012 stood at $360000.0, up from $345000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $360000.0 in Q4 2012, with the low at $345000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Pacira BioSciences | 939.59 Mn | 688.56 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 360,000.00 |
| Dec 31, 2011 | 345,000.00 |